Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken) | ||||||||||||||||||
Abbildung 55: EUROPA-Studie - HOPE-Studie EUROPA study with perindopril 8 mg once daily extends the observations of HOPE, in which cardiovascular events were reduced with ACE inhibition in high-risk patients with coronary heart disease. The risk of patients in EUROPA was lower than in HOPE, which selected older patients (66 vs 60), who had higher percentage of cardiovascular risk disease PVD, hypertension), stroke or diabetes. |
Abbildung 55: EUROPA-Studie - HOPE-Studie
EUROPA study with perindopril 8 mg once daily extends the observations of HOPE, in which cardiovascular events were reduced with ACE inhibition in high-risk patients with coronary heart disease. The risk of patients in EUROPA was lower than in HOPE, which selected older patients (66 vs 60), who had higher percentage of cardiovascular risk disease PVD, hypertension), stroke or diabetes. |
